New systems for the specific delivery and sustained release of dopamine to the brain

Journal of Controlled Release

Volumn 42, Issue 3, 1996, Pages 209-216

  Carelli, Vincenzo ^a   Liberatore, Felice ^a   Scipione, Luigi ^a   Impicciatore, Mariannina ^b   Barocelli, Elisabetta ^b   Cardellini, Mario ^c   Giorgioni, Gianfabio ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Brain specific delivery and release; Chemical delivery system; Dopamine; Prodrug; Rat vacuous chewing behaviour

Indexed keywords

DOPAMINE; DOPAMINE DERIVATIVE; PRODRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BIOAVAILABILITY; BLOOD BRAIN BARRIER; BRAIN; CONTROLLED STUDY; DRUG ANALYSIS; DRUG COMPARISON; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG DOSE; DRUG RELEASE; DRUG SYNTHESIS; FEMALE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MASTICATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHARMACOKINETICS; PHARMACOLOGY; PRIORITY JOURNAL; RAT; REFLEX; STRUCTURE ACTIVITY RELATION; SUSTAINED RELEASE PREPARATION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0030560989     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01366-1     Document Type: Article

References (28)

1. [1] H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger and F. Seitelberg, Brain dopamine and syndromes of Parkinson and Huntington, J. Neurol. Sci. 20 (1973) 415-455.
2. [2] G. Satzinger, Antiepiletics from gamma-aminobutyric acid, Arzeneim.-Forsch./Drug Res. 44 (1994) 261-266.
3. [3] O. Benkert, H. Wetzel and A. Szegedi, Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety and obsessive-compulsive disorder, Int. Clin. Psychopharmacol. 8 (1993) 3-14.
4. [4] K.L. Audus, P.J. Chikhale, D.W. Miller, S.E. Thompson and R.T. Borchart, Brain uptake of drugs: The influence of chemical and biological factor. In: B. Testa (Ed.) Advances in Drug Research, Academic Press, London, UK, 1992, 23, pp. 3-64.
5. [5] A. McRas and A. Dahlstrom, Trasmitter-loaded polymeric microspheres induced regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-dopamine induced Parkinsonism, Neurochem. Int. 1 (1994) 27-33.
6. [6] N. Bodor, H.H. Farag and M.E. Brewster, Site-specific, sustained release of drugs to the brain, Science 214 (1981) 1370-1372.
7. [7] N. Bodor and H.H. Farag, Improved delivery through biological membranes. 11. A redox drug-delivery system and its use for brain-specific delivery of phenylethylamine, J. Med. Chem. 26 (1983) 313-318.
8. [8] N. Bodor and H.H. Farag, Improved delivery through biological membranes. 13. Brain-specific delivery system of dopamine with a dihydropyridine ↔ pyridinium salt type redox delivery system, J. Med. Chem. 26 (1983) 528-534.
9. [9] E. Pop, W. Anderson, K. Prokai-Tatrai, M.E. Brewster, M. Fregly and N. Bodor, Antihypertensive activity of redox derivative of tryptophan, J. Med. Chem. 33 (1990) 2216-2221.
10. [10] N. Bodor and H.H. Farag, Improved delivery through biological membranes. XIV. Brain-specific, sustained delivery of testosterone using a redox chemical delivery system, J. Pharm. Sci. 73(3) (1984) 385-389.
11. [11] N. Bodor, J. McCornack and M.E. Brewster, Improved delivery through biological membranes. XXII. Synthesis and distribution of brain-selective estrogen delivery system, Int. J. Pharm. 35 (1987) 47-59.
12. [12] M.E. Brewster, K.S. Estes and N. Bodor, Improved delivery through biological membranes. 32. Synthesis and biological activity of brain-targeted delivery system for various estradiol derivatives, J. Med. Chem. 31 (1988) 244-249.
13. [13] A. Finazzi-Agrò, L. Avigliano, V. Carelli, F. Liberatore and A. Casini, Evidence for binding of NAD dimers to NAD-dependent dehydrogenases. Biochim. Biophys. Acta 661 (1981) 120-123.
14. [14] V. Carelli, A. Casini, F. Liberatore, S. Tortorella, A. Finazzi-Agrò, F. Polizio and S. El-Sherbini, Pyrrolo quinoline quinone: a versatile biological electron carrier, Med. Chem. Res. 2, (1992), 282-289.
15. [15] V. Carelli, F. Liberatore, A. Casini, R. Mondelli, A. Arnone, I. Carelli, G. Rotilio and I. Mavelli, Dimers of nicotinamide adenine dinucleotide: new evidence for the structure and the involvement in an enzymatic redox process, Bioorg. Chem. 9(3) (1980) 342-351.
16. [16] L. Avigliano, V. Carelli, A. Casini, A. Finazzi-Agrò and F. Liberatore, Oxidation of NAD dimers by horseradish peroxidase, Biochem. J. 226 (1985) 391-395.
17. [17] L. Avigliano, V. Carelli, A, Casini, A. Finazzi-Agrò, F. Liberatore and A. Rossi, Oxidation of nicotinamide coenzyme dimers by one-electron-accepting proteins. Biochem. J. 237 (1986) 919-922.
18. [18] L. Galzigna, L. Garbin, M. Bianchi and A. Marzotto, Properties of two derivatives of γ-aminobutyric acid (GABA) capable of abolishing cardiazol-and bicuculline-induced convulsion in the rat. Arch. Int. Pharmacodin. 235 (1978) 73-85.
19. +, Biochim. Biophys. Acta 1076 (1991) 37-48.
20. [20] L.G. Pellegrino, A.S. Pellegrino and A.S. Cushman, A stereotaxic Atlas of rat brain, Plenum, New York, NY, 1979.
21. [21] A.M. Murray and J.L. Waddington, The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D1-D2 interaction, Eur. J. Pharmacol. 160 (1989) 377-384.
22. [22] S.A. Daly and J.L. Waddington, Behavioural evidence for D1-like dopamine receptor subtypes in rat brain using the new isochroman agonist a 68930 and isoquinoline antagonist BW 7370. Psycopharmacol. 113 (1993) 45-50.
23. [23] H. Rosengarten, J.W. Schweitzer and A.J. Friedhoff, Induction of oral dyskinesias in naive rats by D1 stimulation, Life Sci. 33 (1983) 2479-2482.
24. [24] P. Collins, C.L.E. Broekkamp, P. Jenner and C.D. Marsden, Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat, Psycopharmacology 112 (1993) 428-436.
25. [25] R.P. Downes and J.L. Waddington, Grooming and vacuous chewing induced by SKF 83959, and agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase, Eur. J. Pharmacol. 234 (1993) 135-136.
26. [26] J.W. Simpkins and N. Bodor, The brain-targeted delivery of dopamine using a redox-based chemical delivery system, Adv. Drug Deliv. Rev. 14 (1994) 243-249.
27. [27] A.A. Sinkula, Prodrug approach in drug design, Annual Rep. Med. Chem. 10 (1975) 306-316.
28. [28] A.S. Horn, H. Griever-Kazemier and D. Dijkstra, Brain levels and metabolism of the dopaminergic agonist 2-amino-6,7-dihydroxytetrahydronaphthalene after administration of various prodrugs, J. Med. Chem. 25 (1982) 993-996.